StockData
Shuttle Pharmaceuticals Holdings, Inc. logo

Shuttle Pharmaceuticals Holdings, Inc. (SHPH) stock

SHPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Sep 24, 2026Score 5/30
$4.30+0.06 (+1.42%)

Close on Nov 17, 2026Market cap $4.31MP/E –Yield –

Shuttle Pharmaceuticals operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Shuttle Pharmaceuticals's operating income for the twelve months ending Jun 30, 2026 was -$11.22M. For fiscal 2025 it was -$11.92M. The highest annual figure on record is -$1.74M in fiscal 2021.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$11.92M–
FY2024Dec 31, 2024-$7.70M–
FY2023Dec 31, 2023-$5.89M–
FY2022Dec 31, 2022-$2.34M–
FY2021Dec 31, 2021-$1.74M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$3.95M–
Q1 FY2026Mar 31, 2026-$2.22M–
Q4 FY2025Dec 31, 2025-$2.79M–
Q3 FY2025Sep 30, 2025-$2.27M–
Q2 FY2025Jun 30, 2025-$3.91M–
Q1 FY2025Mar 31, 2025-$2.95M–
Q4 FY2024Dec 31, 2024-$1.78M–
Q3 FY2024Sep 30, 2024-$3.05M–
Q2 FY2024Jun 30, 2024-$1.48M–
Q1 FY2024Mar 31, 2024-$1.38M–
Q4 FY2023Dec 31, 2023-$1.28M–
Q3 FY2023Sep 30, 2023-$1.60M–
Q2 FY2023Jun 30, 2023-$1.47M–
Q1 FY2023Mar 31, 2023-$1.54M–
Q4 FY2022Dec 31, 2022-$530.34K–
Q3 FY2022Sep 30, 2022-$821.47K–
Q2 FY2022Jun 30, 2022-$353.63K–
Q1 FY2022Mar 31, 2022-$638.40K–
Q4 FY2021Dec 31, 2021-$988.54K–
Q3 FY2021Sep 30, 2021-$242.12K–

More Shuttle Pharmaceuticals figures

See a number that looks wrong?